O60563 (CCNT1_HUMAN) Homo sapiens (Human)
Cyclin-T1 UniProtKBInterProSTRINGInteractive Modelling
726 aa; Sequence (Fasta) ; (Isoform 2)
It is possible new templates exist for this target since these models were created.
Available Structures
29 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Crystal structure of HIV-1 Tat complexed with human P-TEFb and AFF4 |
Heteromer P04608; P50750; Q9UHB7; | 8×YT3; 2×SO4; 2×ZN; | ||||
| Assess | ||||||
| Crystal structure of HIV-1 Tat complexed with human P-TEFb |
Heteromer P04608; P50750; | 2×ZN; | ||||
| Assess | ||||||
| Crystal Structure of Human CDK9/cyclinT1 |
Heteromer P50750; | 1×TRS; | ||||
| Assess | ||||||
| crystal structure of P-TEFb complex with AFF4 and Tat |
Heteromer P50750; P69698; Q9UHB7; | 1×ADN; 2×ZN; | ||||
| Assess | ||||||
| Crystal structure of HIV-1 Tat complexed with ATP-bound human P-TEFb |
Heteromer P04608; P50750; | 1×ANP; 1×MG; 2×ZN; | ||||
| Assess | ||||||
| HIV-1 TAR loop in complex with Tat:AFF4:P-TEFb |
Heteromer P04608; P50750; Q9UHB7; | 2×ZN; | ||||
| Assess | ||||||
| TAR complex with HIV-1 Tat-AFF4-P-TEFb |
Heteromer P50750; P69697; Q9UHB7; | 2×ZN; | ||||
| Assess | ||||||
| Structure of CDK9/cyclinT1 in complex with DRB |
Heteromer P50750; | 1×PO4; 5×GOL; 1×RFZ; | ||||
| Assess | ||||||
| Crystal structure of CDK9-Cyclin T1 bound by compound 6 |
Heteromer P50750; | 1×UT5; | ||||
| Assess | ||||||
| CDK9/cyclin T in complex with CAN508 |
Heteromer P50750; | 3×PO4; 1×F18; 2×GOL; | ||||
| Assess | ||||||
| Structure of CDK9 in complex with cyclin T and a 2-amino-4-heteroaryl- pyrimidine inhibitor |
Heteromer P50750; | 1×T7Z; 2×GOL; | ||||
| Assess | ||||||
| Structure of CDK9 in complex with cyclin T and a 2-amino-4-heteroaryl- pyrimidine inhibitor |
Heteromer P50750; | 1×T6Q; | ||||
| Assess | ||||||
| Structure of CDK9 in complex with cyclin T and a 2-amino-4-heteroaryl- pyrimidine inhibitor |
Heteromer P50750; | 1×T3C; 2×GOL; | ||||
| Assess | ||||||
| Structure of CDK9 in complex with cyclin T and a 2-amino-4-heteroaryl- pyrimidine inhibitor |
Heteromer P50750; | 1×T3E; | ||||
| Assess | ||||||
| Crystal Structure of Human CDK9/cyclinT1 in complex with MC180295 |
Heteromer P50750; | 2×TO7; 2×TOJ; 1×PO4; | ||||
| Assess | ||||||
| Structure of CDK9 in complex with cyclin T and a 2-amino-4-heteroaryl- pyrimidine inhibitor |
Heteromer P50750; | 1×T9N; | ||||
| Assess | ||||||
| Crystal Structure of Human CDK9/cyclinT1 with A86 |
Heteromer P50750; | 1×LCI; 2×GOL; | ||||
| Assess | ||||||
| structure of CDK9/cyclin T F241L |
Heteromer P50750; | |||||
| Assess | ||||||
| CDK9-Cyclin-T1 complex bound by compound 24 |
Heteromer P50750; | 1×Q6E; 1×TRS; 1×PO4; | ||||
| Assess | ||||||
| Structure of full length CDK9 in complex with cyclinT and DRB |
Heteromer P50750; | |||||
| Assess | ||||||
| Structure of CDK9/cyclin T1 in complex with inhibitor |
Heteromer P50750; | 1×NJ6; | ||||
| Assess | ||||||
| CDK9/cyclin T1 in complex with KB-0742 |
Heteromer P50750; | 1×VQE; | ||||
| Assess | ||||||
| Crystal Structure of Human CDK9/cyclinT1 in complex with Flavopiridol |
Heteromer P50750; | 3×PO4; 1×CPB; | ||||
| Assess | ||||||
| Crystal Structure of Human CDK9/cyclinT1 in Complex with ATP |
Heteromer P50750; | 1×MG; 1×ATP; 1×TRS; | ||||
| Assess | ||||||
| Structure of CDK9/CyclinT in complex with S-CR8 |
Heteromer P50750; | 1×SLQ; | ||||
| Assess | ||||||
| CDK9/cyclin T in complex with CAN508 |
Heteromer P50750; | 1×F18; | ||||
| Assess | ||||||
| Crystal structure of full-length cdk9 in complex with cyclin t |
Heteromer P50750; | |||||
| Assess | ||||||
| The AFF4 scaffold binds human P-TEFb adjacent to HIV Tat |
Heteromer P50750; Q9UHB7; | 1×AMP; | ||||
| Assess | ||||||
| Cyclin box structure of the P-TEFb subunit Cyclin T1 derived from a fusion complex with EIAV Tat | homo-4-mer | |||||
| Assess | ||||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 6gzh.1.B | monomer | 0.81 | 99.59 | |||
| Assess | ||||||
1 SWISS-MODEL model built on isoform sequence
| Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 2 | 4imy.2.B | monomer | 0.86 | 98.90 | ||
| Assess | ||||||